Home / Market Reports / Medical Care / Global mRNA Synthesis & Manufacturing Market Growth (Status and Outlook) 2024-2030

Global mRNA Synthesis & Manufacturing Market Growth (Status and Outlook) 2024-2030

Global mRNA Synthesis & Manufacturing Market Growth (Status and Outlook) 2024-2030

Product Code:1244035

Published Date: Dec 12,2024

Pages: 102

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global mRNA Synthesis & Manufacturing market size is predicted to grow from US$ 2299 million in 2024 to US$ 3323 million in 2030; it is expected to grow at a CAGR of 6.3% from 2024 to 2030.

mRNA synthesis and manufacturing refer to the processes used to produce messenger RNA (mRNA) molecules for therapeutic or research purposes. The process begins with designing the mRNA sequence to encode a specific protein of interest. This is followed by in vitro transcription, where DNA templates are transcribed into mRNA using enzymes like RNA polymerases. The synthesized mRNA is then purified to remove impurities, capped, and stabilized to enhance its translation efficiency and protect it from degradation. Finally, the mRNA is formulated into delivery systems, such as lipid nanoparticles, to ensure effective delivery into cells. This technology is central to mRNA vaccines and emerging treatments for various diseases.

United States market for mRNA Synthesis & Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for mRNA Synthesis & Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for mRNA Synthesis & Manufacturing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key mRNA Synthesis & Manufacturing players cover Merck KGaA, Thermo Fisher Scientific, GenScript, New England Biolabs, Aldevron, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “mRNA Synthesis & Manufacturing Industry Forecast” looks at past sales and reviews total world mRNA Synthesis & Manufacturing sales in 2023, providing a comprehensive analysis by region and market sector of projected mRNA Synthesis & Manufacturing sales for 2024 through 2030. With mRNA Synthesis & Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Synthesis & Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global mRNA Synthesis & Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Synthesis & Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Synthesis & Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Synthesis & Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Synthesis & Manufacturing.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Synthesis & Manufacturing market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Synthesis
    Purification
    Manufacturing & Scale-up

Segmentation by Application:
    CGT Drugs
    Vaccines

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Merck KGaA
    Thermo Fisher Scientific
    GenScript
    New England Biolabs
    Aldevron
    Promega Corporation
    Sartorius
    WuXi Biologics
    Takara Bio
    GENEWIZ
    TriLink BioTechnologies
    Lonza
    Telesis Bio
    ST Pharm
    Aurigene Pharmaceutical Services